Ledger.Open graph →
SEC Form D · filed April 15, 2021

Gyroscope Therapeutics Ltd

Offering
$148.0M
Sold
$148.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
STEVENAGE, HERTFORDSHIRE, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Renee Gala · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorIan Pitfield · STEVENAGE, HERTFORDSHIRE, United KingdomExecMaha Katabi · South San Francisco, CADirectorDavid Fellows · Louisville, CODirectorJessica Stitt · STEVENAGE, HERTFORDSHIRE, United KingdomExecKhurem Farooq · STEVENAGE, HERTFORDSHIRE, United KingdomExecEdward Lang · STEVENAGE, HERTFORDSHIRE, United KingdomExecJennifer Cook · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorSean Bohen · San Francisco, CADirectorIan Clark · Tuckahoe, NYDirectorJane Hughes · STEVENAGE, HERTFORDSHIRE, United KingdomExecWouter Joustra · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorNadia Waheed · STEVENAGE, HERTFORDSHIRE, United KingdomExecChris Hollowood · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorIan Pitfield · STEVENAGE, HERTFORDSHIRE, United KingdomExecMaha Katabi · South San Francisco, CADirectorDavid Fellows · Foster City, CADirectorJessica Stitt · STEVENAGE, HERTFORDSHIRE, United KingdomExecRenee Gala · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorKhurem Farooq · STEVENAGE, HERTFORDSHIRE, United KingdomExecEdward Lang · STEVENAGE, HERTFORDSHIRE, United KingdomExecJennifer Cook · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorSean Bohen · San Francisco, CADirectorIan Clark · New Rochelle, NYDirectorJane Hughes · STEVENAGE, HERTFORDSHIRE, United KingdomExecWouter Joustra · STEVENAGE, HERTFORDSHIRE, United KingdomDirectorNadia Waheed · STEVENAGE, HERTFORDSHIRE, United KingdomExecChris Hollowood · STEVENAGE, HERTFORDSHIRE, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗